Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing precision cancer therapies. Its pipeline includes small molecule inhibitors targeting genetic and molecular pathways in cancers such as AML, ALL, GIST, and solid tumors. The company emphasizes pairing therapeutics with diagnostics for patient-specific treatment, leveraging translational research, and strategic collaborations to advance targeted, potentially more effective and safer cancer treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.